Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. AMD
4. INFY
5. RNG
6. UNP
7. DGX
8. ACI
9. ROL
10. URI

Go back to Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific
(NASDAQ: ELDN) Delayed: 3.61 -0.13 (3.48%)
Previous Close $3.74    52 Week High $ 
Open $3.76    52 Week Low $ 
Day High $3.76    P/E N/A 
Day Low $3.58    EPS $ 
Volume 456,480